Product Information
METHYLPHENIDATE 5 MG/5 ML SOLN is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0782 per ML under NDC 27808005801. Its NADAC has been published 460 times since Dec 13, 2017.
FDA first approved this application on Jul 23, 2010. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808005801
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091601FDA Approved
7/23/2010
TE Code
AA
On Market Since
3/4/2015
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has been published 460 times since Dec 13, 2017, and over the history we have for it it has declined 88.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0782 per ML |
|---|---|
| All-time high | $0.6611 (Jan 10, 2018) |
| All-time low | $0.0642 (May 20, 2020) |
| 52-week high | $0.0827 |
| 52-week low | $0.0744 |
| Median price | $0.1090 |
| Average price | $0.1352 |
| Largest weekly change | -53.2% (Aug 22, 2018) |
| Weeks tracked | 460 |
| Tracking since | Dec 13, 2017 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG/5 ML SOLN, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0782 per ML (NDC 27808005801), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has declined 88.2%. It has been tracked across 460 weekly CMS publications since Dec 13, 2017.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG/5 ML SOLN?
Since Dec 13, 2017, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has ranged from a low of $0.0642 (May 20, 2020) to a high of $0.6611 (Jan 10, 2018), with a median of $0.1090 per ML.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG/5 ML SOLN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 5 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG/5 ML SOLN?
METHYLPHENIDATE 5 MG/5 ML SOLN (NDC 27808005801) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.